Inventor · disambiguated record
Thomas Jostock
Also filed as: JOSTOCK THOMAS
13 granted patents·11 pending applications·12 citations·filing 2006–2024
86Inventor score
Top patents by PatentIndex Score
24 records- 0187US9994866B2Expression vector system comprising two selection markersNOVARTIS AG·Filed 2016·Granted Jun 12, 2018·3 cites·12 claims
- 0283US10767186B2Organic compoundsNOVARTIS AG·Filed 2016·Granted Sep 8, 2020·2 cites·17 claims
- 0380US11174494B2Expression vector system comprising two selection markersNOVARTIS AG·Filed 2018·Granted Nov 16, 2021·1 cites·23 claims
- 0478US9315844B2Methods for selecting eukaryotic cells expressing a heterologous proteinJOSTOCK THOMAS·Filed 2014·Granted Apr 19, 2016·2 cites·15 claims
- 0577US9534226B2Expression vector system comprising two selection markersJOSTOCK THOMAS·Filed 2010·Granted Jan 3, 2017·2 cites·9 claims
- 0676US8962274B2Methods for selecting eukaryotic cells expressing a heterologous proteinJOSTOCK THOMAS·Filed 2010·Granted Feb 24, 2015·2 cites·11 claims
- 0774US2024425617A1Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodiesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0869US2020370055A1Organic compoundsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0966US2025313878A1IMPROVED PROTEIN PRODUCTION USING miRNA TECHNOLOGYNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1063US11987644B2Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodiesNOVARTIS AG·Filed 2020·Granted May 21, 2024·0 cites·4 claims
- 1163US2022325310A1Novel eukaryotic cells and methods for recombinantly expressing a product of interestNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1262US2022298228A1Novel eukaryotic cells and methods for recombinantly expressing a product of interestNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1361US2014295489A1Organic compoundsASSARAF YEHUDA G·Filed 2014·Application pending·0 cites
- 1459US11242551B2Eukaryotic cells and methods for recombinantly expressing a product of interestNOVARTIS AG·Filed 2014·Granted Feb 8, 2022·0 cites·22 claims
- 1559US11203631B2Eukaryotic cells and methods for recombinantly expressing a product of interestNOVARTIS AG·Filed 2014·Granted Dec 21, 2021·0 cites·16 claims
- 1659US2010330572A1Organic compoundsASSARAF YEHUDA G·Filed 2008·Application pending·0 cites
- 1758US2021244821A1Cho cell expressed het il-15NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1857US10724033B2Cell surface display of polypeptide isoforms by stop codon readthroughNOVARTIS AG·Filed 2017·Granted Jul 28, 2020·0 cites·24 claims
- 1957US9758779B2Cell surface display of polypeptide isoforms by stop codon readthroughJOSTOCK THOMAS·Filed 2009·Granted Sep 12, 2017·0 cites·8 claims
- 2056US2012276579A1Organic compoundsASSARAF YEHUDA G·Filed 2012·Application pending·0 cites
- 2149US2019002589A1Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2248US11807855B2Selection vectors and methods of selecting eukaryotic host cellsNOVARTIS AG·Filed 2014·Granted Nov 7, 2023·0 cites·6 claims
- 2344US10030063B2Production of therapeutic proteins in genetically modified mammalian cellsFORNARO MARA·Filed 2013·Granted Jul 24, 2018·0 cites·13 claims
- 2436US2007274985A1AntibodyDUBEL STEFAN·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Jostock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →